Biocon's Visakhapatnam Facility Receives Positive USFDA Inspection Report with VAI Classification
Aug. 5, 2024, 5:10 p.m.
Biocon Limited has received an Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) from the U.S. Food and Drug Administration (USFDA).
The report pertains to B…
Unlock the Full Filing And Lot More
Access premium insights and stay ahead of the market with Dzambhala Pro.